STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

PSTI PLURISTEM THERAPEUTICS INCORPORATED StockScouter® Report

8

StockScouter® Score

PLURISTEM THERAPEUTICS INCORPORATED, a micro cap company in the healthcare sector, is expected to outperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The multi-period measure of relative price change and consistency is well above average. Positive
  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • Shares are under accumulation by financial institutions. Marginally positive for a small company like PSTI

 

Concerns

  • The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 60% done.
Progress: 100% done.
Low
High

Core Model Grades

B
C
D
A

Previous Ratings

5
7
4